Editorial
Welcome to the first homepage edition of i2P for 2012.
In many ways it has been a slow start to the New Year because of having to deal with the “leftovers” from 2011.
One of those items for i2P was that a third-party provider to the site did not advise of a code change to the security section in our subscribe panel, creating a range of frustrated subscribers not able to get on board.
We apologise to all those potential subscribers who were unable to register with us in the second half of 2011, but if you try once more you should have no problem.
Columns
Rollo Manning: Pharma-Goss
Linda Bryant: Inside NZ
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 2012 Number 1
Health Politics
Neil Johnston: Friends of Science in Medicine
Peter Sayers: Confessions of a Frustrated Pharmacist
James Ellerson: $75.5 million in 5CPA lying idle. Why is it so?EPublications
Heart Disorder Now an Epidemic
Printer-friendly version
Send to friend
PDF version | Staff Writer |
Editing and Researching news and stories about global and local Pharmacy Issues | |
A growing epidemic of the world's most common heart rhythm disorder is resulting in an alarming number of hospital admissions in Australia, according to cardiology researchers.
A research team led by Professor Prash Sanders, from the University of Adelaide and the Cardiovascular Research Centre at the Royal Adelaide Hospital, found that hospital admissions due to atrial fibrillation had more than tripled in Australia over a 15-year period.
These findings are being presented at the European Society of Cardiology's Scientific Congress in Stockholm, Sweden, today. The Congress is the largest annual meeting of doctors and scientists in Europe dedicated to the study of cardiovascular disease.
Professor Sanders, the Knapman Chair of Cardiology Research at the University of Adelaide, says the results are a wakeup call for doctors and healthcare authorities.
"There are very few studies that have looked at hospitalisation rates across an entire country due to atrial fibrillation, and none in recent years.
"This study highlights the enormous public health burden of atrial fibrillation on hospitals and the need for not only better treatments for this increasingly common condition, but also preventative strategies to stop it occurring in the first place," Professor Sanders says.
Chief investigator Mr Chris Wong, a final-year medical student at the University of Adelaide, says atrial fibrillation is the most common, sustained heart rhythm disorder in humans, affecting almost one in 10 people over the age of 80.
"Importantly, left untreated, it can have devastating consequences such as stroke and death. One in five strokes are due to this heart rhythm disorder," Mr Wong says.
The researchers looked at all hospitalisations due to atrial fibrillation in Australia (population 22 million) over a 15-year period from 1993 to 2008
The 200% increase in hospitalisations was despite a decrease in the length of stay for each admission.
"This highlights the fact that not only have the absolute number of admissions increased significantly, but also the percentage of the population hospitalised for atrial fibrillation is continuing to increase at an alarming rate," Mr Wong says.
The researchers also discovered that Indigenous Australians had greater rates of hospitalisation for this condition, and at younger ages.
Return to homeResearch Reports
Dr Andrew Byrne & Associates: Tranquillizer use rife amongst OTP subjects world-wide, most legally prescribedPractice Development
Neil Retallick: Are the discounters impacting community pharmacy beyond margin erosion? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Support services for pharmacists and doctors in the United Kingdom – Part 3 Royal Medical Benevolent Fund | open full screen
Staff Writer: Catch the early wave in 2012 and secure your valuable CPD Credits at the Guild Pharmacy Academy – NSW Convention | open full screen
Information Technology
Dr David More: Australian Health Information Technology LinksIndigenous Health
Preventive Medicine
Gerald Quigley: It’s Time!If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Post new comment